CTRI/2024/02/062951招募中Unknown
Epigenetic profiling of circulating Histone H3 in the patients of rheumatoid arthritis with pulmonary complications: A pilot study of novel proteomics approach
The Executive Director, All India Institute of Medical Sciences, Rajkot0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients with Rheumatoid arthritis having pulmonary complications. (diagnosis will be based on ACR/EULAR criteria using clinical history, examination, immunological investigation, radiological investigations)
- •Healthy age and gender matched volunteers without any pulmonary disease, systemic illness or connective tissue disorders.
排除标准
- •Patients with pulmonary manifestations which are not attributable to Rheumatoid arthritis.
- •Refusal of consent for participation
研究者
相似试验
已完成
不适用
Quantification of histamine H3 receptor density in human brain using [11C]M-2Healthy volunteersJPRN-UMIN000011422ational Institute of Radiological Sciences13
招募中
不适用
Detection of global methylation and histone acetylation in aggressive variants of thyroid carcinoma by immunohistochemical analysisBasic epigenetic events (global methylation and histone acetylation) in aggressive variants of thyroid cancer including anaplastic,medullary and poorly differentiated carcinomasThyroid carcinoma,epigenetics,methylation,acetylationTCTR20180314001Faculty of Medicine, Chulalongkorn University100
已完成
不适用
Examination of the correlation of the histamine H3 receptor density and the neurocognitive functioJPRN-UMIN000022937ational Institute of Radiological Sciences10
已完成
不适用
Establishment of epigenetic approach to identify high risk patients of colorectal cancer in ulcerative colitislcerative ColitisJPRN-UMIN000036203Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine200
进行中(未招募)
1 期
A clinical trial to test the safety and effectiveness of a new drug, tefinostat, for patients with chronic myelomonocytic leukaemiaChronic myelomonocytic leukaemia (CMML)MedDRA version: 19.0Level: PTClassification code 10009018Term: Chronic myelomonocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-002281-23-GBCardiff University40
